SCHEMBL12305065

SCHEMBL12305065

C=C(C)NCCc1ccc(O)c(O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.70
ALDH1A1 P00352 6/20 0.70
HSD17B10 Q99714 4/20 0.70
KDM4E B2RXH2 4/20 0.70
HIF1A Q16665 3/20 0.70
LMNA P02545 2/20 0.70
HPGD P15428 2/20 0.70
BLM P54132 2/20 0.70
PTGS1 P23219 2/20 0.70
ALOX15 P16050 3/20 0.62
MAPK1 P28482 3/20 0.62
TP53 P04637 2/20 0.62
THPO P40225 2/20 0.62
CYP1A2 P05177 1/20 0.62
TSHR P16473 1/20 0.62
NFKB1 P19838 1/20 0.62
GMNN O75496 1/20 0.61
GFER P55789 1/20 0.61
PMP22 Q01453 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17266372 0.86 MAPT (0.66) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL30446328 0.85 MAPT (0.73) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL400288 0.85 MAPT (0.73) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL30616852 0.82 MAPT (1.00) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL328568 0.82 MAPT (1.00) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL14164293 0.81 ERCC1 (0.57) MAPTALDH1A1HSD17B10KDM4EHIF1A
Water SCHEMBL1321161 0.81 MAPT (0.97) MAPTALDH1A1HSD17B10KDM4EHIF1A
Hydrochloric Acid SCHEMBL28839145 0.81 MAPT (0.97) MAPTALDH1A1HSD17B10KDM4EHIF1A
Potassium SCHEMBL29870134 0.81 MAPT (0.97) MAPTALDH1A1HSD17B10KDM4EHIF1A
SCHEMBL29870429 0.81 MAPT (0.97) MAPTALDH1A1HSD17B10KDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110218158-A1 DNA CYTOSINE DEAMINASE INHIBITORS REGENTS OF THE UNIVERSITY OF MINNESOTA 2011-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218158-A1 DNA CYTOSINE DEAMINASE INHIBITORS DCTD, APOBEC3A, UNG MAPT 4260/4885ALDH1A1 795/4885HSD17B10 1581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.